INIS Stock - International Isotopes Inc.
Unlock GoAI Insights for INIS
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $13.90M | $12.27M | $11.18M | $9.66M | $9.36M |
| Gross Profit | $8.65M | $7.38M | $6.29M | $5.74M | $5.46M |
| Gross Margin | 62.2% | 60.2% | 56.3% | 59.4% | 58.3% |
| Operating Income | $6,901 | $-776,299 | $917,181 | $2,572 | $3.22M |
| Net Income | $8,574 | $-869,016 | $-310,705 | $-2,377,132 | $-2,216,212 |
| Net Margin | 0.1% | -7.1% | -2.8% | -24.6% | -23.7% |
| EPS | $0.00 | $-0.00 | $-0.00 | $-0.01 | $-0.01 |
International Isotopes Inc. manufactures and sells nuclear medicine calibration and reference standards, cobalt-60 products, and radiopharmaceutical and radiochemical contract manufacturing services in the United States and internationally. It operates through five segments: Nuclear Medicine Standards, Cobalt Products, Radiochemical Products, Radiological Services, and Fluorine Products. The Nuclear Medicine Standards segment manufactures sources and standards associated with single photon emission computed and positron emission tomography imaging, patient positioning, and calibration or operational testing of dose measuring equipment for the nuclear pharmacy industry. It offers flood sources, dose calibrators, rod sources, flexible and rigid rulers, spot and pen point markers, and various specialty design items. The Cobalt Products segment produces bulk cobalt; fabricates cobalt capsules for radiation therapy and various industrial applications; and recycles expended cobalt sources. The Radiochemical Products segment produces and distributes various isotopically pure radiochemicals and sodium iodide I-131 generic drug product for medical, industrial, and research applications. The Radiological Services segment provides flood source disposal and gemstones processing services. The Fluorine Products segment is involved in the production of small-scale qualification samples of high purity fluoride gas for various industrial applications, as well as development of laboratory and analytical processes required to support the planned uranium de-conversion and fluorine extraction facility. It sells its products directly to end users and distributors. International Isotopes Inc. was incorporated in 1995 and is headquartered in Idaho Falls, Idaho.
Visit WebsiteEarnings History & Surprises
INISEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | May 13, 2026 | — | — | — | — |
Q1 2026 | Mar 2, 2026 | — | — | — | — |
Q4 2025 | Nov 14, 2025 | — | $-0.00 | — | — |
Q3 2025 | Aug 13, 2025 | — | $-0.00 | — | — |
Q2 2025 | May 15, 2025 | — | $-0.00 | — | — |
Q1 2025 | Mar 4, 2025 | — | $0.00 | — | — |
Q4 2024 | Nov 12, 2024 | — | $0.00 | — | — |
Q3 2024 | Aug 14, 2024 | — | $-0.00 | — | — |
Q2 2024 | Apr 1, 2024 | — | $-0.00 | — | — |
Q1 2024 | Mar 29, 2024 | — | $-0.00 | — | — |
Q4 2023 | Nov 14, 2023 | — | $-0.00 | — | — |
Q3 2023 | Aug 14, 2023 | — | $-0.00 | — | — |
Q2 2023 | May 15, 2023 | — | $-0.00 | — | — |
Q2 2023 | Apr 6, 2023 | — | $-0.00 | — | — |
Q4 2022 | Nov 15, 2022 | — | $-0.00 | — | — |
Q3 2022 | Aug 16, 2022 | — | $-0.00 | — | — |
Q2 2022 | May 17, 2022 | — | $0.00 | — | — |
Q2 2022 | Apr 4, 2022 | — | $0.00 | — | — |
Q4 2021 | Nov 12, 2021 | — | $-0.00 | — | — |
Q3 2021 | Aug 17, 2021 | — | $-0.00 | — | — |
Latest News
Frequently Asked Questions about INIS
What is INIS's current stock price?
What is the analyst price target for INIS?
What sector is International Isotopes Inc. in?
What is INIS's market cap?
Does INIS pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to INIS for comparison